3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Neoplasms
3
Keratosis, Actinic
3
Carcinoma, Basal Cell
3
Urinary Bladder Neoplasms
2
Skin Neoplasms
2
Lymphoma, Non-Hodgkin
2
Carcinoma, Squamous Cell
2
Stomatitis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Glioblastoma
1
Depression
1
Deglutition Disorders
1
Carcinoma, Non-Small-Cell Lung
1
Anxiety Disorders
1
Interventions
Cisplatin
76
Radiotherapy
44
pembrolizumab
39
Cetuximab
38
Paclitaxel
34
Carboplatin
33
Docetaxel
30
Fluorouracil
25
Radiotherapy, Intensity-Modulated
22
Nivolumab
18
Drug Therapy
14
Radiation
12
Erlotinib Hydrochloride
9
cemiplimab
8
Magnetic Resonance Spectroscopy
8
130-nm albumin-bound paclitaxel
8
durvalumab
7
atezolizumab
7
Cyclophosphamide
7
Afatinib
7
Surgical Procedures, Operative
6
Panitumumab
6
Leucovorin
6
Chemoradiotherapy
6
fludarabine
5
aldesleukin
5
Radiosurgery
5
Oxaliplatin
5
Methotrexate
5
Gemcitabine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Squamous Cell
×
Niacinamide
×
Clear all
NCT05955924
2025-02-21
SPRINTR
Women's College Hospital
Phase 3
Recruiting
396 enrolled
NCT03769285
2023-04-06
SPRINTR-Pilot
Women's College Hospital
Phase 2
Unknown
120 enrolled